R emifentanil is a potent, ultra-short-acting opioid, which acts as a μ-receptor agonist with rapid onset and short duration of action. It does not cause elevation in plasma histamine levels after administration of higher doses. Therefore, it is often used as an adjunct to general anesthesia during surgery. Animal experiments 1 and clinical studies 2, 3 of opioid analgesia suggested that brief opioid exposure can enhance pain sensitivity, which was called opioid-induced hyperalgesia. 4 Intraoperative remifentanil might trigger postoperative secondary hyperalgesia and increase analgesic requirements. 5, 6 The functions mentioned above might be related to spinal N-methyl-d-aspartate receptor (NMDAR)-dependent central sensitization. 7, 8 Functional NMDA receptors consist of NR2B subunits and one or more subunits of NR2. Tyrosine phosphorylation of the NR2B subunits in the spinal cord plays a critical role in the development and maintenance of central sensitization and hyperalgesia. 9 Furthermore, Tyr-1472 appears to be the major phosphorylation site among the potential tyrosine phosphorylation sites of NR2B. However, the underlying mechanisms are still unclear.
Sensitization of nociceptive pathways has been considered a neurocentric plastic mechanism, and it has become increasingly recognized that spinal glial cells might be dynamic regulators of this neuronal network. 10 Spinal glial cells might function in central sensitization and pathological pain, which has been shown in experimental animal models of peripheral inflammation, spinal injury, and nerve injury. [11] [12] [13] In these pain models, the activation of glia is associated with an increase of proinflammatory cytokines such as tumor necrosis factor α (TNF-α), interleukin (IL)-6, and IL-1β. [14] [15] [16] These cytokines together with the abnormal activation of NMDARs in the spinal dorsal horn may provoke hyperalgesia. 16, 17 The activation of NMDARs in spinal glia and the release of proinflammatory cytokines may be important for the development and maintenance of hyperalgesia.
Cannabinoids bind to the G protein-coupled cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2) to induce analgesia. 18 CB2 is expressed in immune cells and in the central nervous system (CNS). [19] [20] [21] In addition, studies show the presence of CB2 in microglia and astrocytes. 22, 23 In various experimental pain models, CB2-selective agonists, such as JWH015, produce antinociception. 24, 25 In addition, JWH015 may not invoke central side effects associated with activation of CB1, such as hyperactivity, hypothermia, and catalepsy in persistent pain states. 14, 26 Compared with the BACKGROUND: Hyperalgesia and neuroinflammation are associated with glia, which consists of macroglia and microglia. In this study, we used a selective cannabinoid receptor type 2 (CB2) agonist JWH015 to investigate remifentanil-induced postoperative hyperalgesia. METHODS: Mechanical allodynia and thermal hyperalgesia after postoperative hyperalgesia and intrathecal injection of JWH015 were assessed by the paw withdrawal mechanical threshold and paw withdrawal thermal latency tests. We used immunohistochemistry and immunoblotting to investigate the effect of JWH015 on CB2 receptor, NR2B subunits, activated glial cells, and proinflammatory cytokine expression in rats after remifentanil-induced postoperative hyperalgesia. RESULTS: Postoperative hyperalgesia was induced by intraoperative infusion of remifentanil. Glial cells were activated, and expression levels of several genes were significantly increased, including interleukin 6, tumor necrosis factor α, CB2, and the NR2B subunit phosphorylated at Tyr-1472 (p-NR2B). Intrathecal injection of JWH015 significantly inhibited glial cell activation, suppressed expression of interleukin 6, tumor necrosis factor α, and p-NR2B, and stimulated CB2 expression, thus attenuating postoperative hyperalgesia. However, these phenomena were abolished in the group that was preadministered with AM630.
CONCLUSIONS:
The activation of glia, the production of proinflammatory cytokines, and the expression of CB2 and p-NR2B in the spinal dorsal horn increase significantly during the process of remifentanil-induced hyperalgesia. These changes can be regulated by pretreatment with JWH015, which may be the main mechanism underlying the antihyperalgesia effects of JWH015. Thus, we speculated that the activation of CB2 might mediate a spinal immune response by suppressing glial function and lead to analgesia. The function of CB2 has not been studied under a remifentanil-induced hyperalgesia condition in a rat model of postoperative pain. In light of these reports, it is possible that JWH015 may stimulate the expression of CB2, inhibit the activation of spinal glial cells, and suppress the production of proinflammatory cytokines. In addition, the expression and function of NMDARs in the spinal dorsal horn may be affected.
METHODS

Animals and Surgeries
Adult male Sprague Dawley rats (weighing 220-250 g) were obtained from the Laboratory Animal Center of Drum Tower Hospital. Animals were habituated individually under a 12 to 12 hours light-dark cycle at a constant room temperature of 24°C with free access to food and water. All experiments were approved by the Animal Care and Use Committee of Affiliated Drum Tower Hospital of Medical College of Nanjing University and conformed to the guidelines for the use of laboratory animals. 28 Plantar incisional surgery was performed as previously described. 29 Rats were anesthetized with sevoflurane (2%) via nose mask. The plantar surface of the right hindpaw was prepared in a sterile manner with 10% povidone-iodine solution. A longitudinal 1-cm incision was made through the skin and fascia, starting at 0.5 cm from the edge of the heel and extending toward the toes of the right hindpaw. The plantaris muscle was increased in level by using forceps and incised longitudinally, leaving the muscle origin and insertion intact. After homeostasis with gentle pressure, the skin was closed with 2 mattress sutures of 5-0 nylon. The incision site was covered with aureomycin ointment.
Drugs and Treatments
Remifentanil hydrochloride (batch number: 100601) was purchased from Humanwell Pharmaceutical Co., Ltd., China. CB2 agonist JWH015 ((2-methyl-1-propyl-1H-indol-3-yl)-1-naphtha-lenylmethanone) and CB2 antagonist AM630 (6-iodo-2-methyl-1-(2-(4-morpholinyl) ethyl)-1H-indol-3-yl) (4-methoxyphenyl) methanone) were purchased from Sigma (Sigma Chemical Co., St. Louis, MI). Sevoflurane (batch number: 10072031) was purchased from Hengrui Medicine Co, Ltd., China. JWH015 (10 μg), and AM630 (15 μg) was dissolved in the vehicle of dimethylsulfoxide and normal saline, and the ratio of dimethylsulfoxide to normal saline was 1:4. The JWH015 solution (10 μL) and AM630 solution (10 μL) were administered by intrathecal injection between the fourth and fifth lumbar vertebrae (L4-L5) by means of a lumbar puncture needle.
14 Remifentanil (0.04 mg/kg) was also dissolved in saline (NaCl 0.9%). AM630 was injected 30 minutes before the agonist JWH015. JWH015 was injected 30 minutes before plantar incision. Remifentanil was infused subcutaneously to the rat's abdomen over a period of 30 minutes by using an apparatus pump. The infusion rate was 0.8 mL/h. Control animals received the same volume of saline in identical conditions. Doses of agents were based on previous studies and our preliminary experiments. In our experiments, all but the largest doses of agents were effective.
Experimental Grouping
All rats were anesthetized with sevoflurane (2%) via a nose mask. For intrathecal treatments, we used 6 groups of rats (n = 9 in each group): group C1 (rats underwent a sham procedure consisting of the administration of sevoflurane and the same volume of vehicle without incision); group I1 (rats underwent a surgical incision and the same volume of vehicle); group J1 (rats underwent intrathecal injection of JWH015 30 minutes before plantar incision, a surgical incision, and subcutaneous infusion of the same volume of vehicle); group R1 (rats received intrathecal injection of the same volume of vehicle 30 minutes before plantar incision, a surgical incision, and subcutaneous infusion of remifentanil at the time of surgical incision over a period of 30 minutes); group JR1 (rats received intrathecal injection of JWH015 30 minutes before plantar incision, a surgical incision, and subcutaneous infusion of remifentanil at the time of surgical incision over a period of 30 minutes); group AJR1 (rats received intrathecal injection of AM630 30 minutes before JWH015 injection, intrathecal injection of JWH015 30 minutes before plantar incision, a surgical incision, and subcutaneous infusion of remifentanil at the time of surgical incision over a period of 30 minutes).
All animals were acclimatized to the animal care unit and various apparatuses for a week before experiments. After the habituation period, paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) tests were performed at 24 hours before and 2, 6, 24, and 48 hours after the surgical procedure. Data obtained from 24 hours before the surgical procedure were used as baseline. Specimens from groups of intrathecal treatments were collected just after behavioral tests at 24 and 48 hours after the surgical procedure (n = 6 from each group).
Behavioral Tests
Rats were habituated to the testing environment for 3 days and for 1 hour each day before baseline testing. PWMTs were examined by applying a von Frey filament to the plantar surface of each hindpaw. 30 The filaments (2-15 g bending force; Stoelting, Wood Dale, IL) were presented, in ascending order of strength, perpendicular to the plantar surface with sufficient force to cause slight bending against the paw and were held for 6 seconds with a 5-minute interval between each stimulation. Each mouse was tested 5 times per stimulus strength. The cutoff force was 15g. PWTL was performed according to previously published methods. 31 Temperature was set to achieve baseline latency at 22 seconds and a cutoff of 25 seconds.
Immunohistochemistry
While under deep anesthesia with pentobarbital sodium (100 mg/kg, intraperitoneal), rats were perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4. The spinal cord L3-L5 segments were removed, fixed, and transferred to 30% sucrose for frozen sections. The sections were blocked for 60 minutes at room temperature with 10% (v/v) normal fetal bovine serum (Vector Laboratories, Peterborough, United Kingdom). The primary antibodies of rabbit polyclonal anti-OX-42 antibody (1:200, Chemicon, Temecula, CA), rabbit polyclonal anti-GFAP (glial fibrillary acidic protein) antibody (1:500, Abcam, Burlingame, CA), and rabbit polyclonal anti-p-NR2B antibody (1:250, Abcam) were used, and samples were then incubated for 48 hours at 4°C. After washing, the secondary antibody (Alexa Fluor 488, 1:500, Abcam) was used, and samples were further incubated at 4°C overnight. Sections were mounted on glass slides, air-dried, and covered with coverslips by using Aquamount (Fisher Scientific, Ottawa, Canada). Images were taken at ×40, ×200 and ×400 magnification by using the Leica TCS SP2 multiphoton confocal microscope (Leica Microsystems, Wetzlar, Germany). Images were randomly selected for further analysis. Fluorescence intensities of these images from different groups were analyzed by using Image-Pro Plus analysis software (Media Cybernetics, Inc., Rockville, MD).
Western Blot Analyses
Rats were killed rapidly by decapitation after anesthesia. Fresh tissue samples from spinal cord dorsal horn were collected by laminectomy. Lumbar spinal segments were divided into the ipsilateral and contralateral side and the dorsal and ventral part and stored in liquid nitrogen. Tissue samples were homogenized in lysis buffer. The homogenate was centrifuged at 13,000 rpm for 10 minutes at 4°C, and supernatant was removed. Protein concentration was determined by the BCA Protein Assay Kit (Thermo Fisher Scientific Life Science Research, Pudong, China), following the manufacturer's instructions. Protein samples were separated on SDS-PAGE gel and transferred to polyvinylidene difluoride filters (Millipore, Billerica, MA). The filters were blocked with 5% milk and then immunoblotted by using antibodies against OX-42 (Abcam, 1:500 dilution), GFAP (Abcam, 1:1000 dilution), IL-6 (Santa Cruz Biotechnology, Inc., Santa cruz, CA, 1:400 dilution), TNF-α (Abcam, 1:600 dilution), CB2 (Abcam, Cambridge, United Kingdom, 1:600 dilution), NR2B (Abcam, 1:500 dilution), and NR2B (phospho Tyr-1472) (Abcam, 1:500 dilution). The membrane was rinsed with Tris-HCl buffer saline and incubated with the secondary antibody of polyclonal goat anti-rabbit IgG (Abcam, 1:5000 dilution). The blots were developed in Electro-ChemiLuminescence solution (DuPont-NEN, Boston, MA) for 1 minute and exposed to hyper-films (Amersham Biosciences, Piscataway, NJ) for 1 to 10 minutes. β-actin (1:10,000, Santa Cruz Biotechnology, Inc., Santa cruz, CA) was used as the loading and blotting control. The gray value of each band was measured with a computer-assisted imaging analysis system (IPLab software, Scanalytics, Fairfax, VA).
Statistical Analyses
All data were expressed as mean ± SD (standard deviation). Repeated-measures analysis of variance were performed to determine differences among groups at each time point. Each measure was conducted between groups treated with drugs and groups treated with vehicles in data of PWMT, PWTL, Western blotting, and immunohistochemistry. Oneway analysis of variance was used to determine differences in PWMT, PWTL data, Western blotting, and immunohistochemistry results before surgery. A P-value <0.05 was considered significant. Multiple pairwise comparisons were performed by using Bonferroni correction to compare differences between the materials over time and groups. The significance level over different time points was set at 0.0125 (0.05/4), and significance level over different groups was set at 0.003 (0.05/15).
RESULTS
JWH015 Attenuates Pain Behaviours After Remifentanil-Induced Postoperative Hyperalgesia
To assess pain behavior after remifentanil-induced postoperative hyperalgesia, mechanical allodynia and thermal hyperalgesia experiments were performed (Fig. 1) . Compared with baseline and group C1, the plantar incision (group I1) induced a significant decrease in mechanical allodynia and thermal hyperalgesia thresholds (P = 0.002). At 24 hours after incision, PWMT (Fig. 1A) and PWTL (Fig. 1B) in group C1 were 13.40g ± 1.13g and 22.61 ± 1.26 seconds, respectively, whereas group I1 were 8.42g ± 1.68g and 16.96 ± 2.27 seconds, respectively. When compared with group I1, intraoperative infusion of remifentanil (group R1) further decreased the threshold for mechanical allodynia and thermal hyperalgesia induced by the plantar incision, with PWMT and PWTL decreased to 6.35g ± 0.98g and 13.57 ± 1.04 seconds, respectively, at 24 hours after incision. Both mechanical allodynia and thermal hyperalgesia were observed on the ipsilateral side after plantar incision, followed by remifentanil-induced postoperative hyperalgesia, which lasted at least 48 hours. In contrast, pretreatment with JWH015 (group JR1) significantly reduced the enhancement of mechanical allodynia and thermal hyperalgesia induced by remifentanil from 6 to 48 hours (P < 0.001). At 24 hours after incision, PWMT and PWTL in group JR1 increased to 10.49g ± 1.37g and 20.55 ± 1.93 seconds, respectively. However, the effect of JWH015 on pain behavior induced by remifentanil was inhibited by intrathecal injection of the CB2 receptor antagonist AM630 (group AJR1) (P < 0.001). In group AJR1, PWMT and PWTL decreased to 6.45g ± 1.02g and 13.72 ± 0.89 seconds, respectively, at 24 hours after incision. Detailed data for groups C1, I1, R1, J1, JR1, and AJR1 at time points of 2, 6, and 48 hours are not shown.
JWH015 Inhibits the Expression of Astrocytes and Microglia in the Spinal Dorsal Horn
Further study of the expression of glia suggests that expression of astrocytes and microglia in spinal dorsal horn changed after plantar incision surgery. GFAP is the specific astrocyte marker and OX-42 is the specific microglial marker. Thus, to evaluate the activation of astrocytes and microglia in the spinal dorsal horn, we performed immunostaining by using anti-GFAP antibody and anti-OX-42 antibody (Figs. 2 and 3 ) at 24 hours after incision. Compared with those in the sham rats, the activated astrocytes (Fig. 2 ) and microglia cells (Fig. 3 ) typically exhibited hypertrophy with thicker processes, and larger, densely stained cell bodies after plantar incision surgery. Pretreatment with JWH015 inhibited the activation of astrocytes (Fig. 2) and microglia www.anesthesia-analgesia.org
ANESTHESiA & ANAlgESiA (Fig. 3) . Furthermore, after remifentanil-induced postoperative hyperalgesia, pretreatment with JWH015 inhibited the activation of astrocytes (Fig. 2) and microglia (Fig. 3) . However, the inhibiting effect of JWH015 on activation of astrocytes ( Fig. 2) and microglia (Fig. 3) was abolished after pretreatment with AM630 (P < 0.001). Detailed data for immunostaining are not shown.
To quantify the expression levels of GFAP and OX-42, we performed Western blot analysis at 24 and 48 hours after surgery (Fig. 4 and Fig. 5 ). Similar results were observed. After remifentanil-induced postoperative hyperalgesia in the spinal dorsal horn (group R1), a significant increase in expression levels of astrocytes and microglia markers was observed (P < 0.001). For example, at 24 hours after surgery, the expression levels of GFAP and OX-42 in group C1 were 0.54 ± 0.04 and 0.45 ± 0.03, respectively, whereas in group R1 were 1.36 ± 0.07 and 1.29 ± 0.06, respectively. However, the expression levels of GFAP and OX-42 in group JR1 were significantly decreased to 0.97 ± 0.02 and 1.01 ± 0.06, respectively (P < 0.001). In addition, the suppressive effect of JWH015 on expression of GFAP and OX-42 was further inhibited by pretreatment with the CB2 receptor antagonist AM630 (Fig. 5 ) at 24 hours after surgery (P < 0.001). Detailed data for groups C1, I1, R1, J1, JR1, and AJR1 at 48 hours are not shown. Collectively, these results show that intrathecal administration of JWH015 significantly suppresses the expression of astrocyte and microglia at 24 and 48 hours after surgery.
JWH015 Inhibits the Production of Proinflammatory Cytokines in the Spinal Dorsal Horn
To investigate the time-course effects of JWH015 on proinflammatory cytokines in spinal dorsal horn after remifentanil administration, we tested the expression of several key factors (Figs. 6 and 7) . Consistent with pain behaviors, remarkable upregulation of IL-6 and TNF-α was observed after the surgery and remifentanil administration in the spinal dorsal horn (P < 0.001) (Fig. 6, A and B) . For example, the expression levels of IL-6 and TNF-α were 0.13 ± 0.01 and 0.12 ± 0.01 in group C1, and were 0.87 ± 0.04 and 0.78 ± 0.03 in group R1, respectively, at 24 hours after surgery. Compared with group R1, intrathecal delivery of JWH015 significantly suppressed the production of IL-6 and TNF-α (P < 0.001), with an IL-6 level of 0.48 ± 0.02 and TNF-α of 0.27 ± 0.01 at 24 hours. However, the expression levels of IL-6 and TNF-α increased in mice pretreated with AM630 compared with mice receiving JWH015 (JR1) (P < 0.001) (Fig. 7) . Detailed data for groups C1, I1, R1, J1, JR1, and AJR1 at 48 hours are not shown.
JWH015 Decreases the Expression and Phosphorylation of NMDAR
Previous studies have confirmed that excitatory synaptic transmission enhanced by proinflammatory mediators is one of the main mechanisms involved in central sensitization, 16 ,32 so we further examined the expression and phosphorylation of the NMDA receptor in the spinal dorsal horn. We performed immunostaining and Western blot analyses with antibodies against NR2B (a main subunit of NMDAR) and its phosphorylated form at Tyr-1472 (p-NR2B). Consistent with the pain behavior results and the expression of proinflammatory cytokines, the expression of p-NR2B increased markedly in spinal dorsal horn after remifentanil administration (Figs. 8-10 ), whereas expression was decreased significantly in JWH015-treated mice (P < 0.001). Meanwhile, there was no significant difference in expression of total NR2B (t-NR2B) among the groups. At 24 hours after surgery, as shown by Western blot Figure 1 . Graph of pain behaviours after remifentanil-induced postoperative hyperalgesia (n = 9/each). A, Paw withdraw mechanical threshold (PWMT), and B, Thermal latency (PWTL) were examined at 5 time points (0, 2, 6, 24, 48 hours after plantar incision). Group C1 rats had a sham procedure consisting of administration of sevoflurane and the same volume of vehicle without incision; group I1 rats had a surgical incision and the same volume of vehicle; group J1 rats had intrathecal injection of JWH015 30 minutes before plantar incision; group R1 rats had intrathecal injection of the same volume of vehicle 30 minutes before plantar incision, a surgical incision and subcutaneous remifentanil infusion at the time of surgical incision over a period of 30 minutes; group JR1 rats had intrathecal injection of JWH015 30 minutes before plantar incision in remifentanil-treated rats; group AJR1 rats had intrathecal injection of AM630 plus JWH015 30 minutes before plantar incision in remifentanil-treated rats. "*" suggested a significant difference compared with baseline, "#" suggested a significant difference compared with group C1, " ◇ " suggested a significant difference compared with group I1, " △ " suggested a significant difference compared with group R1, " ▽ " suggested a significant difference compared with group JR1. results (Fig. 9A) , the level of p-NR2B in group C1 was 0.60 ± 0.03, while in group R1, it was 1.40 ± 0.02. In group JR1, the p-NR2B level decreased to 0.81 ±0.03. In addition, the level of p-NR2B in the spinal dorsal horn increased in mice pretreated with AM630 compared with mice receiving JWH015 (JR1) (P < 0.001) at 24 hours after surgery (Fig. 10) . Detailed data for immunostaining and for groups C1, I1, R1, J1, JR1, and AJR1 at 48 h are not shown.
JWH015 Stimulates the Expression of CB2 in the Spinal Dorsal Horn
To investigate the time-course effects of JWH015 on CB2 in spinal dorsal horn after remifentanil administration, we measured the expression of CB2 (Fig. 11) . Upregulation of activated CB2 was observed after the surgery and remifentanil administration in the spinal dorsal horn (Fig. 11) . Intrathecal delivery of JWH015 further significantly increased the production of activated CB2 after surgery (P < 0.001). At 24 hours after surgery, the expression level of activated CB2 in group C1, group R1, and group JR1 was 0.31 ± 0.02, 0.94 ± 0.06, and 1.50 ± 0.08, respectively. However, pretreatment with AM630 inhibited the increase by JWH015 (P < 0.001), with a CB2 level of 0.98 ± 0.05 at 24 hours. Detailed data for group I1 and J1 are not shown.
DISCUSSION
It has been reported that intraoperative infusion of remifentanil is associated with postoperative hyperalgesia. 33, 34 Activation of glial cells, proinflammatory cytokines, and phosphorylation of NMDA receptors may contribute to the development and maintenance of opioid-induced hyperalgesia. In our study, intrathecal treatment with JWH015 attenuated pain behaviors, increased CB2 expression, suppressed the expression of IL-6 and TNF-α, inhibited activation of glia, and prevented the increase and phosphorylation of the NMDAR. We speculated that activated glia, such as astrocytes and microglia, produce and release IL-6 and TNF-α, contributing to different features of pathological pain. We Figure 2 . The effects of JWH015 on activation of astrocytes in the spinal dorsal horn by using astrocyte marker glial fibrillary acidic protein (GFAP) (n = 6/each). Expression of GFAP was analyzed by immunohistochemistry and observed under confocal microscope. The upper panel shows the representative immunohistochemical staining results of groups C1, I1, J1, R1, JR1, and AJR1. Magnification, ×200. The lower panel shows the immunofluorescence intensity of GFAP in groups C1, I1, J1, R1, JR1, and AJR1. Fluorescence intensities were analyzed by using Image-Pro Plus analysis software. "#" suggested a significant difference compared with group C1, " ◇ " suggested a significant difference compared with group I1, " △ " suggested a significant difference compared with group R1, " ▽ " suggested a significant difference compared with group JR1. Abbreviations are described in the legend of Figure 1. www.anesthesia-analgesia.org
ANESTHESiA & ANAlgESiA showed that JWH015 inhibits the activation of astrocytes and microglia, as well as the production of proinflammatory cytokines and expression and activation of NMDARs in the spinal dorsal horn. By this mechanism, JWH015 may improve pain behaviors.
Endocannabinoids play important roles in regulation of analgesia. Our results suggested that effective analgesia could be achieved through stimulation of spinal CB2 as described in neuropathic or cancer-induced pain models. 14, 35, 36 The role of CB2 for the relief of remifentanilinduced hyperalgesia has not been described. In this study, our rat model of postoperative pain demonstrated that activation of the CB2 signaling pathway could prevent postoperative allodynia and hyperpathia induced by remifentanil and inhibit overexpression of spinal glia cells and proinflammatory cytokines up to 48 hours after surgery. In addition, we also observed that the CB2 agonist JWH015 upregulated spinal CB2 protein expression, which is contradictory to well-accepted concepts. A possible reason is that it may not be the increase in numbers of CB2 but rather the activation of the receptor that is important. Furthermore, CB2 activation by JWH015 inhibited the phosphorylation of NR2B in spinal cord. However, the antihyperalgesia effect of JWH015 was blocked by the CB2 receptor antagonist AM630.
The NMDAR is one of the glutamate receptors known to play an important role in synaptic transmission, neuronal plasticity, and central sensitization in the CNS. 8, 37 It may be involved in development and maintenance of central sensitization underlying the behavioral manifestations of hyperalgesia as well. 8, 38 Our previous study indicated that ketamine, a noncompetitive NMDAR antagonist, could inhibit the NMDAR and development of hyperalgesia in a rat model of postoperative pain. 39 Similarly, in the present study, our results show that remifentanil administration increased the expression of NR2B tyrosine phosphorylation at Tyr-1472 in spinal cord at 24 and 48 hours after surgery.
Chemical transmission between neurons and glial cells is essential for integration in the CNS. It is reported that the functional NMDARs that were involved in neuronalglial signal transmission were expressed in glial cells. Injuries in peripheral tissue or nerve could induce CNS glial activation, mainly the activation of astrocytes and microglia. 41, 42 Proinflammatory cytokines, including IL-6 and TNF-α in the spinal cord and brain, are released by the activated glia and play important roles in mediating exaggerated pain states. 43, 44 Guo et al. 15 suggested that glia activation and IL-1 receptor signaling contribute directly to the modulation of neuronal NMDAR and facilitate sensitization by increasing glutamate release from presynaptic terminals, thus promoting the activity of NMDARs of postsynaptic terminals. 46, 47 Therefore, central sensitization could be enhanced and maintained by activation of glial cells and release of proinflammatory cytokines. 17, 48, 49 NMDAR-dependent central sensitization facilitates the development and maintenance of hyperalgesia and persistent pain. 7, 47, 50 Taken together, these findings suggest that activation of spinal glia and release of proinflammatory cytokines contribute to the development and maintenance of hyperalgesia by the NMDAR of postsynaptic terminals.
In addition, astrocytes play a major role in the clearance of synaptic glutamate via high-affinity glutamate reuptake transporters such as glutamate transporters (GLT)-1 and glutamate aspartate transporters expressed on their surface. 51 Activated astrocytes are less efficient at clearing glutamate when there are low levels of GLT-1 expression, high levels of glutamate aspartate transporters, and high levels of proinflammatory cytokines. 52 The release of proinflammatory cytokines, such as TNF-α, may suppress GLT-1. 53 The inhibition of glutamate transporters in the spinal cord produces hypersensitivity, which is blocked by NMDAR antagonists. 54 It is possible that active astrocytes produce hyperalgesia by modulating glutamate transmission.
Proinflammatory mediators released from glia, including cytokines, chemokines, and neuromodulators, can act not only on neuronal functions but also on glial cells themselves. In this study, we only investigated 2 proinflammatory cytokines. However, this does not mean that the other mediators are not important. Adenosine triphosphate released from activated astrocytes has been proposed as another candidate involved in neuron-glia communication by acting on both pre-and postsynaptic neurons and facilitating synaptic transmission. 55 The function of these factors in regulating hyperalgesia remains to be determined. Magnification, ×200. The lower panel shows the immunofluorescence intensity of p-NR2B in groups C1, I1, J1, R1, JR1, and AJR1. Image-Pro Plus analysis software was used for fluorescence intensity analysis. "#" suggested a significant difference compared with group C1, " ◇ " suggested a significant difference compared with group I1, " △ " suggested a significant difference compared with group R1, " ▽ " suggested a significant difference compared with group JR1. The same abbreviation was used as in Figure 1. www.anesthesia-analgesia.org
ANESTHESiA & ANAlgESiA Figure 9 . Western blot of NR2B in the spinal dorsal horn (n = 6/each). The expression levels of NR2B in inactivated and activated form (t-NR2B and p-NR2B) were tested at 24 and 48 hours after plantar incision compared with Sham group (A and B). β-actin was used as internal control. "#" suggested a significant difference compared with group C1, " ◇ " suggested a significant difference compared with group I1, " △ " suggested a significant difference compared with group R1. The same abbreviation was used as in Figure 1 . Figure 10 . Western blot of NR2B in the spinal dorsal horn (n = 6/each). The expression levels of NR2B in inactivated and activated form (t-NR2B and p-NR2B) were tested at 24 hours after plantar incision compared with remifentanil-induced postoperative hyperalgesia (A and B). β-actin was used as internal control. The same abbreviation was used as in Figure 1 . " △ " suggested a significant difference compared with group R1, " ▽ Numerous studies demonstrate that the activation of spinal CB2 causes antinociception in various pain models, 14, 26, 35, 36 but the mechanisms of CB2-mediated analgesia are still controversial. CB2 is expressed in microglia and astrocytes 14, 22, 23, 27, 36 and selectively stimulated by JWH015, which could markedly suppress glial cells (microglia and astrocytes) and their production of TNF-α and nitric oxide. 27, 56 The lack of spinal glial activation could inhibit hyperalgesia and persistent pain. Activation of CB2 may facilitate analgesia by regulation of glial cells and their production of proinflammatory cytokines. Our results showed the reduced expression levels of glial cells, proinflammatory cytokines (TNF-α and IL-6), and NR2B tyrosine phosphorylation after pretreatment with JWH015. Our results provide a basis for further investigation of the mechanisms of JWH015-mediated reduction in hyperalgesia.
In summary, the selective CB2 agonist JWH015 may relieve remifentanil-induced hyperalgesia through CB2 stimulation. Our results also showed the activation of glia, the increased levels of proinflammatory cytokines (IL-6 and TNF-α) in spinal cord, and the increase in p-NR2B after remifentanil treatment. These results provide further evidence for the key roles of glia activation, proinflammatory cytokines, and NR2B tyrosine phosphorylation in the development of hyperalgesia induced by remifentanil. In addition, proinflammatory cytokines and glial cells in the CNS may be potential targets of persistent pain conditions, leading to the discovery of effective therapeutic agents, such as JWH015. E Figure 11 . Western blot of CB2 receptor in the spinal dorsal horn (n = 6/each). The expression levels of CB2 receptor were tested at 24 hours after plantar incision compared with Sham group. β-actin was used as an internal control. "#" suggested a significant difference compared with group C1, " ◇ " suggested a significant difference compared with group I1, " △ " suggested a significant difference compared with group R1, " ▽ " suggested a significant difference compared with group JR1. The same abbreviation was used as in Figure 1 .
